![David Kerr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Kerr
Oprichter bij
Oxford Cancer Biomarkers Ltd.
Profiel
David Kerr is the founder of Oxford Cancer Biomarkers Ltd. (founded in 2012) and holds the title of Director.
He is currently working as a Director & Chief Medical Officer at Ingenox Therapeutics Ltd., a Researcher at the University of Oxford, Chief Medical Officer at Celleron Therapeutics Ltd., and Principal at OxOnc Development LP.
Actieve functies van David Kerr
| Bedrijven | Functie | Begin |
|---|---|---|
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology Operates as an oncology development company | Corporate Officer/Principal | - |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Oprichter | 01-01-2012 |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Hoofd Techniek/Wetenschap/O&O | - |
Ingenox Therapeutics Ltd.
 Ingenox Therapeutics Ltd. BiotechnologyHealth Technology Develops drugs and precision cancer vaccines for advanced & treatment-resistant cancers | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
76
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology Operates as an oncology development company | Health Technology |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. BiotechnologyHealth Technology Develops drugs and precision cancer vaccines for advanced & treatment-resistant cancers | Health Technology |
Kies MarketScreener 
